Acute Lower Back Pain after Intralesional Injection of Collagenase Clostridium histolyticum for Peyronie's Disease.
John T SigalosMichelle K LiDar A YoffeNeilufar ModiriMing-Yeah Y HuDyvon T WalkerThomas W GaitherAlvaro SantamariaKeith V RegetsSriram Venkata EleswarapuJesse Nelson MillsPublished in: The Journal of urology (2022)
This single-center, retrospective analysis suggests that intralesional collagenase injections for Peyronie's disease may cause acute lower back pain in up to 6% of patients. Patients may benefit from counseling regarding this risk. Incidence rises with additional rounds of treatment. Prospective safety data regarding >8 injections do not exist. No patient had long-term sequelae of back pain.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- liver failure
- prognostic factors
- peritoneal dialysis
- ultrasound guided
- patient reported outcomes
- case report
- respiratory failure
- risk factors
- machine learning
- big data
- acute respiratory distress syndrome
- hiv infected
- artificial intelligence
- extracorporeal membrane oxygenation
- data analysis